Skip to main content
WeightCited

Omega-3 para Metabolic Syndrome

B Evidencia Al menos un ensayo aleatorizado lo respalda, con resultados mayoritariamente consistentes.

Systematic review of 44 RCTs found omega-3 significantly reduces triglycerides by 15-30% and reduces waist circumference by 0.81 cm. Fish oil combined with exercise produces greater body fat reduction than either alone. Benefits include PPAR-gamma activation and anti-inflammatory effects.

B

Conclusión

Systematic review of 44 RCTs found omega-3 significantly reduces triglycerides by 15-30% and reduces waist circumference by 0.81 cm. Fish oil combined with exercise produces greater body fat reduction than either alone. Benefits include PPAR-gamma activation and anti-inflammatory effects.

Key Study Findings

Randomized Controlled Trial 12 weeks Open-label
Nutritional effect on lipoproteins and their subfractions in patients with Psoriatic Arthritis: a 12-week randomized …
Dose: Mediterranean diet vs: Standard diet Outcome: HDL/LDL subfractions and metabolic syndrome

Población: Patients with psoriatic arthritis

Randomized Controlled Trial n=45 16 weeks
Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids.
Dose: 4 g/day P-OM3 vs: Healthy controls + MetSyn placebo Outcome: Lipoprotein oxylipin profiles

Población: MetSyn patients vs healthy controls

Key Statistics

44

Estudios

3000

Participantes

↑

Positive

B

Calificación

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

general:
250-500 mg EPA+DHA/day
antiinflammatory:
2,000-4,000 mg/day
weightmanagement:
1,000-3,000 mg EPA+DHA/day

Límite superior: 5,000 mg EPA+DHA/day (FDA GRAS); may increase bleeding time at high doses

Dosificaciones estudiadas en la investigación

Dosificación Duración Efecto N
Mediterranean diet 12 weeks Positive --
4 g/day P-OM3 16 weeks Positive 45

Mejor momento para tomar: With meals containing fat for absorption; may split dose AM/PM

Safety & Side Effects

Efectos secundarios reportados

  • ⚠ Fishy aftertaste
  • ⚠ GI discomfort
  • ⚠ Increased bleeding time (at high doses)
  • ⚠ Nausea

Interacciones conocidas

  • ● Blood thinners (may enhance anticoagulant effect at high doses)
  • ● Blood pressure medications (additive effect)
  • ● Orlistat (reduced absorption)

Ingesta máxima tolerable: 5,000 mg EPA+DHA/day (FDA GRAS); may increase bleeding time at high doses

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does Omega-3 help with Metabolic Syndrome?
Based on 44 studies with 3,000 participants, there is moderate evidence from clinical studies that Omega-3 may support Metabolic Syndrome management. Our evidence grade is B (Good Evidence).
How much Omega-3 should I take for Metabolic Syndrome?
Studies have used various dosages. A commonly studied range is 250-500 mg EPA+DHA/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3?
Reported side effects may include Fishy aftertaste, GI discomfort, Increased bleeding time (at high doses), Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 and Metabolic Syndrome?
We rate the evidence as Grade B (Good Evidence). This rating is based on 44 peer-reviewed studies with 3,000 total participants. The overall direction of effect is positive.

Otros ingredientes para Metabolic Syndrome

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

References

  1. [1] Daniele Scherer et al.. Adv Rheumatol. 2024. Nutritional effect on lipoproteins and their subfractions in patients with Psoriatic Arthritis: a 12-week randomized trial-the DIETA trial. doi:10.1186/s42358-024-00389-5 PubMed
  2. [2] Seema Mehdi et al.. Biochem Biophys Rep. 2023. A review on linking stress, depression, and insulin resistance via low-grade chronic inflammation. doi:10.1016/j.bbrep.2023.101571 PubMed
  3. [3] Jannis Kountouras et al.. Clin Nutr. 2022. Comments on "dose-related meta-analysis for omega-3 fatty acids supplementation on major adverse cardiovascular events". doi:10.1016/j.clnu.2022.06.015 PubMed
  4. [4] Gregory C Shearer et al.. Prostaglandins Leukot Essent Fatty Acids. 2018. Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids. doi:10.1016/j.plefa.2017.10.006 PubMed
  5. [5] Leyre Martínez-Fernández et al.. Prostaglandins Other Lipid Mediat. 2015. Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome. doi:10.1016/j.prostaglandins.2015.07.003 PubMed

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.